<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-103636</identifier>
<setSpec>1138-3593</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Iatrogenic adrenal insufficiency</dc:title>
<dc:description xml:lang="en">Adrenal insufficiency is a disease caused by the deficit in production and/or secretion of glucocorticoids. The aetiology of Adrenal Insufficiency (AI) can be classified into primary and secondary, and it should be taken that the incidence and prevalence of the secondary formare much higher than the primary form. One of the main causes of AI is due to prescription of exogenous steroids. It can be taken orally, which is more common, or topically. The latter is more uncommon but it should not be a a reason for ruling it out. We have to be aware when giving a topical treatment and to monitor the frequency our patients ask for the prescription (AU)</dc:description>
<dc:creator>Cabal García, A. A</dc:creator>
<dc:creator>Rodríguez Virgili, J</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La insuficiencia suprarrenal (IS) es un síndrome causado por el déficit de producción y/o secreción de glucocorticoides. La etiología de la IS puede dividirse en primaria y secundaria, y debemos tener en consideración que la incidencia y la prevalencia de la secundaria son mucho mayores que las de la primaria. Una de las causas principales de IS es la administración exógena de esteroides que puede ser de forma oral, más generalizada, o bien de forma tópica. Esta última más infrecuente, pero no por ello hemos de olvidarla y debemos tenerla presente a la hora de administrar un tratamiento tópico y en pacientes que con frecuencia solicitan dicha medicación (AU)</dc:description>
<dc:source>SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. Impr.);38(7): 468-471, oct. 2012. tab</dc:source>
<dc:identifier>ibc-103636</dc:identifier>
<dc:title xml:lang="es">Insuficiencia suprarrenal iatrogénica</dc:title>
<dc:subject>^d24339^s22045</dc:subject>
<dc:subject>^d7231^s22080</dc:subject>
<dc:subject>^d22460^s22073</dc:subject>
<dc:subject>^d308^s22073</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d312^s22032</dc:subject>
<dc:subject>^d312^s22057</dc:subject>
<dc:subject>^d312^s22012</dc:subject>
<dc:subject>^d6082^s22073</dc:subject>
<dc:subject>^d3965</dc:subject>
<dc:subject>^d7231^s22054</dc:subject>
<dc:subject>^d24339^s22074</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d312^s22016</dc:subject>
<dc:subject>^d312^s22027</dc:subject>
<dc:subject>^d19059</dc:subject>
<dc:type>article</dc:type>
<dc:date>201210</dc:date>
</metadata>
</record>
</ibecs-document>
